|
|
800 North Research Parkway, Suite 370 Oklahoma City, OK 73104-3698 USA phone:405.271.9025 fax:405.271.9026
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.inoveon.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Solutions to detect, stage and monitor diseases affecting the eye. |
 |
| Management |
| P. Lloyd Hildebrand, President and Chief Operating Officer; Stephen R. Fransen, Chief Medical Officer |
| |
|
|
| |
|
| Keywords |
| services, digita, eye, retinal, Diabetes, blood sugar, diabetic, metabolic, insulin, retinopathy, macular degeneration, glaucoma, stl, j2008 |
|
|
|
| Description |
|
Inoveon is a medical services company that delivers solutions to detect, stage and monitor diseases affecting the eye: diabetic retinopathy, macular degeneration, and glaucoma. Inoveon's initial target is to help patients and their providers improve diabetic retinopathy care through Inoveon diagnostic service centers that are co-located in high volume diabetes care sites. |
 |
| Products / Services |
Inoveon's product is the digital iScan service to detect, stage and monitor diabetic retinopathy in the primary diabetes care setting.
|
 |
| Technology / Differentiation |
| The iScan procedure scans 100% of the retinal area recommended by the NIH protocols. It images seven specific areas of each eye (see image below) in 3D to help your physician find diabetic changes early and provide timely, vision-saving care. After checking your vision and dilating your eyes, the iScan technician will image different parts of each eye. These images are sent for specialized analysis, and a report is sent back to your doctor the next day. |
 |
 |
|
|
|
|
|
|